“Everything has been Dramatically Changed Since The Outbreak Began”: A Descriptive Qualitative Study of Cancer Care Experiences of Patients and Oncology Nurses during the COVID‑19 Pandemic

Ali Mostafaei, Neda Kabiri, Deniz Naghibi, Rahim Khodayari‑Zarnaq, Sakineh Hajebrahimi, Fatemeh Sadeghi‑Ghyassi, Siamak Salehi

Abstract


Background: Cancer during the novel coronavirus disease 2019 (COVID‑19) pandemic has changed, leading to challenges in the management of the two serious health conditions of cancer and COVID‑19. This study was conducted to explore the experiences of cancer care among hospitalized patients with cancer and oncology nurses in the COVID‑19 pandemic environment.

Materials and Methods: This descriptive qualitative study included interviews with patients with cancer and oncology nurses. Observations and field notes were recorded. In this study, we purposively recruited 11 patients and 10 oncology nurses from a tertiary referral hospital affiliated with the Tabriz University of Medical Sciences, northwest Iran. Face‑to‑face interviews were conducted between June and July 2021. The interviews were recorded, transcribed verbatim, open‑coded, and analyzed thematically. All these steps were managed using MAXQDA 10.

Results: Three themes were generated regarding patients’ and nurses’ experiences of cancer care during the COVID‑19 pandemic: 1) feeling scared and neglected, 2) appearance of fundamental changes in all aspects of life, and 3) facing challenges beyond routine cancer care.

Conclusions: This study demonstrates the experiences of a “vulnerable” population during the COVID‑19 pandemic. Understanding the experiences of patients with cancer and frontline healthcare providers during this unprecedented time of COVID‑19 can help provide guidance and support for health policymakers in evidence‑informed decision‑making for cancer care beyond the COVID‑19 pandemic era.


Keywords


COVID‑19, oncology nursing, patients, qualitative research

Full Text:

PDF

References


Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends—An update. Cancer Epidemiol Biomarkers Prev 2016;25:16‑27.

Roshandel G, Ferlay J, Ghanbari‑Motlagh A, Partovipour E, Salavati F, Aryan K, et al. Cancer in Iran 2008 to 2025: Recent incidence trends and short‑term predictions of the future burden Int J Cancer 2021;149:594‑605.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020;395:507‑13.

Addeo A, Friedlaender A. Cancer and COVID‑19: Unmasking their ties. Cancer Treat Rev 2020;88:102041.

Akbarzadeh MA, Hosseini M‑S. Implications for cancer care in Iran during COVID‑19 pandemic. Radiother Oncol 2020;148:211‑2.

Richards M, Anderson M, Carter P, Ebert BL, Mossialos E. The impact of the COVID‑19 pandemic on cancer care. Nature Cancer 2020;1:565‑7.

Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID‑19‑infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Ann Oncol 2020;31:894‑901.

Umutesi G, Shyirambere C, Bigirimana JB, Urusaro S, Uwizeye FR, Nahimana E, et al. Cancer care delivery innovations, experiences and challenges during the COVID‑19 pandemic: The Rwanda experience. J Glob Health 2021;11:03067.

AlWaheidi S, Sullivan R, Davies EA. Additional challenges faced by cancer patients in Gaza due to COVID‑19. Ecancermedicalscience 2020;14:ed100.

Wilson AD, Onwuegbuzie AJ, Manning LP. Using paired depth interviews to collect qualitative data. The Qualitative Report. 2016;21:1549-73.

Braun V, Clarke V. Thematic analysis. In: Cooper H, Camic P, Long D, Panter A, Rindskopf D, Sher K, editors. APA Handbook of Research Methods in Psychology. American Psychological Association; 2012.

Lincoln YS, Guba EG. Criteria for Assessing Naturalistic Inquiries as Reports. 1988.

Mirlashari J, Ebrahimpour F, Salisu WJ. War on two fronts: Experience of children with cancer and their family during COVID‑19 pandemic in Iran. J Pediatr Nurs 2021;57:25‑31.

Seven M, Bagcivan G, Pasalak SI, Oz G, Aydin Y, Selcukbiricik F. Experiences of breast cancer survivors during the COVID‑19 pandemic: A qualitative study. Support Care Cancer 2021;29:6481‑93.

Ebrahimi A, Khorasani P, Ahmadi M, Andalib S, Mousavi SMH. the safe coping strategy of nurses working in the care units of patients with COVID‑19: A qualitative study. Iran J Nurs Midwifery Res 2023;28:214‑9.

Gualandi R, De Benedictis A, De Marinis MG, Tartaglini DJC. Managing the journey of patients under chemotherapy in a pandemic era: A nursing perspective. Chemotherapy 2021;65:115‑8.

Gatellier L, Shankar A, Dewi LKM, Hussain QM, Dendup Wangdi T, Sukumaran DB, et al. The impact of COVID‑19 on cancer care in the post pandemic world: Five major lessons learnt from challenges and countermeasures of major Asian cancer centres. Asian Pac J Cancer Prev 2021;22:681‑90.

Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R, et al. The impact of the COVID‑19 pandemic on cancer deaths due to delays in diagnosis in England, UK: A national, population‑based, modelling study. Lancet Oncol 2020;21:1023‑34.

Sud A, Torr B, Jones ME, Broggio J, Scott S, Loveday C, et al. Effect of delays in the 2‑week‑wait cancer referral pathway during the COVID‑19 pandemic on cancer survival in the UK: A modelling study. Lancet Oncol 2020;21:1035‑44.

Blay J, Boucher S, Le Vu B, Cropet C, Chabaud S, Perol D, et al. Delayed care for patients with newly diagnosed cancer due to COVID‑19 and estimated impact on cancer mortality in France. ESMO Open 2021;6:100134.

Kenis I, Theys S, Daem M, Decoene E, Demolder V, Duprez V, et al. Experiences of patients with cancer and their relatives confronted with COVID‑19 related delay or change in care: A qualitative study. J Adv Nurs 2022;78:4150‑64.

Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI. A war on two fronts: Cancer care in the time of COVID‑19. Ann Intern Med 2020;172:756‑8.

Siow MY, Walker JT, Britt E, Kozy JP, Zanzucchi A, Girard PJ, et al. What was the change in telehealth usage and proportion of no‑show visits for an orthopaedic trauma clinic during the COVID‑19 pandemic? Clin Orthop Relat Res 2020;478:2257‑63.

Guarino M, Cossiga V, Fiorentino A, Pontillo G, Morisco F. Use of telemedicine for chronic liver disease at a single care center during the COVID‑19 pandemic: Prospective observational study. J Med Internet Res 2020;22:e20874.

Mostafaei A, Sadeghi‑Ghyassi F, Kabiri N, Hajebrahimi S. Experiences of patients and providers while using telemedicine in cancer care during COVID‑19 pandemic: A systematic review and meta‑synthesis of qualitative literature. J Support Care Cancer 2022;30:10483‑94.

Saab R, Obeid A, Gachi F, Boudiaf H, Sargsyan L, Al‐Saad K, et al. Impact of the coronavirus disease 2019 (COVID‐19) pandemic on pediatric oncology care in the Middle East, North Africa, and West Asia Region: A report from the Pediatric Oncology East and Mediterranean (POEM) Group. Cancer 2020;126:4235‑45.

Ranney ML, Griffeth V, Jha AK. Critical supply shortages—the need for ventilators and personal protective equipment during the Covid‑19 pandemic. N Engl J Med 2020;382:e41.

Jazieh AR, Akbulut H, Curigliano G, Rogado A, Alsharm AA, Razis ED, et al. Impact of the COVID‑19 pandemic on cancer care: A global collaborative study. JCO Glob Oncol 2020;6:1428‑38.

Xu H, Intrator O, Bowblis JR. Shortages of staff in nursing homes during the COVID‑19 Pandemic: What are the driving factors? J Am Med Dir Assoc 2020;21:1371‑7.

Takian A, Bakhtiari A, Ostovar A. Universal health coverage for strengthening prevention and control of noncommunicable diseases in COVID‑19 era. Med J Islam Repub Iran 2020;34:153.


Refbacks

  • There are currently no refbacks.